Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00112866
What this trial is testing

Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 30
Not applicableEnded earlyNCT03698162
What this trial is testing

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

Who this might be right for
Brain MetastasesGlioma of BrainBrain Tumor+1 more
University of Southern California 15
Early research (Phase 1)Looking for participantsNCT05609994
What this trial is testing

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Who this might be right for
Low Grade Glioma of Brain
Katy Peters, MD, PhD 48
Very early researchEnded earlyNCT03965494
What this trial is testing

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Early research (Phase 1)Study completedNCT02658981
What this trial is testing

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Who this might be right for
GlioblastomaGliosarcomaRecurrent Brain Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Early research (Phase 1)Study completedNCT00392119
What this trial is testing

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

Who this might be right for
Brain NeoplasmsBrain TumorBrain Cancer+1 more
BioTex, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00006102
What this trial is testing

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT00238251
What this trial is testing

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Swiss Cancer Institute 59
Testing effectiveness (Phase 2)Study completedNCT02333565
What this trial is testing

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

Who this might be right for
Recurrent MeningiomasResistant Meningiomas
Assistance Publique Hopitaux De Marseille 20
Testing effectiveness (Phase 2)Ended earlyNCT00248534
What this trial is testing

Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Not applicableStudy completedNCT01342757
What this trial is testing

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult GlioblastomaDepressionRecurrent Adult Brain Tumor
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT02614794
What this trial is testing

Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen Inc. 612
Early research (Phase 1)Study completedNCT01722305
What this trial is testing

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaCentral Nervous System LymphomaIntraocular Lymphoma+3 more
Mayo Clinic 29
Early research (Phase 1)Study completedNCT00003970
What this trial is testing

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00040573
What this trial is testing

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

Who this might be right for
GliomaBrain Neoplasm
TransMolecular 18
Early research (Phase 1)Study completedNCT01550523
What this trial is testing

Pilot Immunotherapy Trial for Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma of Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 13
Early research (Phase 1)Study completedNCT02808650
What this trial is testing

Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Childhood Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+2 more
Children's Oncology Group 30
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Early research (Phase 1)Active Not RecruitingNCT02442297
What this trial is testing

T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors

Who this might be right for
Brain Tumor, RecurrentBrain Tumor, Refractory
Baylor College of Medicine 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05660408
What this trial is testing

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

Who this might be right for
Recurrent Pulmonary OsteosarcomaRecurrent High-grade Glioma
University of Florida 36
Next Page